Local Report Belgium

Bristol Myers Squibb’s mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We firmly believe that there is more we can do – beyond delivering innovative medicines – to help support patients and their loved ones. It is this believe that led to the creation of the initiative ‘Because there is more to do’.

We asked people for their opinion of BMS and pharmaceutical companies in general; what are their unmet needs; and what more they think pharma can do to help support patients along their treatment journeys and contribute to society.

This report presents findings of the Belgian patient & professional survey.* A public EU wide survey** was also conducted, which was open to people across eight countries.

Across the patient journey there are a broad range of needs, dependent on individuals’ exact situation and conditions. However patients, carers, patient associations and physicians in Belgium identify the following areas as key needs across the patient journey.

Patients, carers, patient associations and physicians in Belgium identified solutions that can improve patient experiences along their journey.

This survey is the starting point for a deeper engagement with patient groups and the healthcare community in Belgium. We will now explore with partners, ideas for new initiatives and activities that respond to the needs that people have voiced. 

^{* The patient & professional survey of stakeholders in Belgium was based on two anonymous online surveys: one with feedback from 120 primary care physicians. cardiologists and oncologists; another with responses from 30 oncology or atrial fibrillation patients. and caregivers of patients with these conditions. In addition. exploratory qualitative research was done with patient advocacy groups. to gain greater insights.}

^{** Respondents from Austria, Belgium. Denmark. Finland. the Netherlands. Norway, Switzerland and Sweden contributed to the public survey.}